BMWS22 Post Event Summary

As the global biopharmaceutical industry continues to grow and evolve, companies are constantly facing pressures to focus on the patient as they improve the quality, efficacy, cost, and compliance of their life-saving products. A steady march of innovative new large molecule products are steadily coming into commercial production, but a whole new new generation of medicine is also on the way. Advanced Therapy Medicinal Products (ATMPs) including Cell and Gene Therapies (CGTs), are at the brink of creating the next and perhaps biggest industry sector pharmaceuticals have ever seen, and important decisions are being made right now about how today’s brightest minds are going to contribute to the shaping and maturing of this exciting and emerging new range of of patient-saving breakthroughs. There is so much to discuss!

The Biomanufacturing World Summit brings together the “who’s who” of biomanufacutring and technical operations executives, cutting-edge technology providers and media partners for North America’s premier biologics event.

See who’s attending